Abstract
Coagulation and fibrinolysis disorders are very common in cancer patients, especially in lung cancer patients. These disorders not only cause thrombosis and diffuse intravascular coagulation, but also play a critical role in cancer growth, invasion and metastasis. Coagulation and fibrindysis system factors, such as platelet, procoagulant, D-dimer, uPA factors, AT Ⅲ and TAT, have obvious prognostic significance in lung cancer. Key words: Lung neoplasms; Blood coagulation; Fibrinolysis ; Prognosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
